New patent for Amneal drug LYVISPAH

Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are three patents protecting…

The post New patent for Amneal drug LYVISPAH appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog